The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

Mohammed Al Gergawi honoured for dedicated leadership
Sheikh Abdullah reaffirms solidarity with Saudi Arabia
UAE President and Putin discuss developments in Middle East in phone call
Abu Dhabi court jails teacher for assaulting 4 students
UAE food aid enters Gaza through Rafah Crossing
UAE carriers cancel more flights to Saudi Arabia
Abu Dhabi performs robotic surgery to prevent colon cancer
UAE Cabinet approves AED 292.5 billion for 2027-2029
